Synthetic approaches to the 2003 new drugs.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2004-11-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389557043402900PMID 15579116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emtricitabine

  2012cited by this paper
• The year's new drugs.

  2004cited by this paper
• Synthetic approaches to the 2002 new drugs.

  2004cited by this paper
• Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder

  2004cited by this paper
• Alfuzosin for the management of benign prostate hyperplasia

  2003cited by this paper
• Application of the Lewis acid-Lewis base bifunctional asymmetric catalysts to pharmaceutical syntheses: stereoselective chiral building block syntheses of human immunodeficiency virus (HIV) protease inhibitor and beta3-adenergic receptor agonist.

  2003cited by this paper
• Aprepitant – a novel NK1-receptor antagonist

  2003cited by this paper
• Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.

  2003cited by this paper
• Efficient synthesis of NK(1) receptor antagonist aprepitant using a crystallization-induced diastereoselective transformation.

  2003cited by this paper
• Everolimus in cardiac-transplant recipients.

  2003cited by this paper
• Review of tadalafil in the treatment of erectile dysfunction

  2003cited by this paper
• Effective treatment of erectile dysfunction with vardenafil.

  2003cited by this paper
• Practical asymmetric synthesis of aprepitant, a potent human NK-1 receptor antagonist, via a stereoselective Lewis acid-catalyzed trans acetalization reaction.

  2002cited by this paper
• Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

  2002cited by this paper
• Effects of cetirizine and epinastine on the skin response to histamine iontophoresis.

  2001cited by this paper
• Comparative efficacy of mycophenolate sodium (MPS) and mycophenolate mofetil (MMF) with and without cyclosporine in rat transplantation models.

  2001cited by this paper
• Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

  1999cited by this paper
• New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development.

  1998cited by this paper
• Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist.

  1998cited by this paper
• Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

  1998cited by this paper
• Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.

  1995cited by this paper
• [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.

  1994cited by this paper
• Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1- pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy.

  1993cited by this paper
• Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia.

  1993cited by this paper
• Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.

  1993cited by this paper
• Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids.

  1992cited by this paper
• Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels.

  1989cited by this paper
• Synthesis and antihypertensive activity of a series of 4-amino-6,7-dimethoxyquinazoline derivatives.

  1986cited by this paper
• Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.

  1984cited by this paper
• Histamine H2 receptor antagonists. 1. Synthesis of N-cyano and N-carbamoyl amidine derivatives and their biological activities.

  1984cited by this paper
• THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS.

  1963cited by this paper

• Naphthoquinone Functionalized Chiral and Achiral Secondary Amines: Synthesis, Characterization, DFT and Molecular Docking Studies

  2025cites this paper
• Phosphine-Promoted Synthesis of Naphthoquinones Fused with Cyclopentadienyl Moiety Via Ring Expansion: Synthesis, Reactivity, and Ring Contraction Via [1,5] Sigmatropic Rearrangement

  2024cites this paper
• Aromatic and olefinic C-H alkenylation by catalysis with spirocyclic NHC Ru(IV) pincer complex

  2023cites this paper
• A Triphenylphosphine-Based Microporous Polymer for a Wittig Reaction Cycle in the Solid State.

  2023cites this paper
• Synthetic Approaches to the New Drugs Approved During 2021.

  2023cites this paper
• Synthetic Approaches to the New Drugs Approved During 2020.

  2022cites this paper
• Design, synthesis and investigation of the mechanism of action underlying anti-leukemic effects of the quinolinequinones as LY83583 analogs.

  2021cites this paper
• Synthetic Approaches to the New Drugs Approved During 2018.

  2020cites this paper
• Design, synthesis and anticancer activity of 2-amidomethoxy-1,4-naphthoquinones and its conjugates with Biotin/Polyamine.

  2020cites this paper
• Systematic study on catalytic arsa-Wittig reaction.

  2020cites this paper
• AuCl3-Catalyzed Ring-Closing Carbonyl-Olefin Metathesis.

  2019cites this paper
• Synthetic Approaches to the New Drugs Approved During 2017.

  2019cites this paper
• One-Pot Protocol To Synthesize 2-Aminophenols from Anilines via Palladium-Catalyzed C–H Acetoxylation

  2019cites this paper
• Virtual Screening of 1,4-Naphthoquinone Derivatives for Inhibition of a Key Cancer Signaling Protein, AKT1 Kinase

  2019cites this paper
• Synthesis, Structure Characterization, and Biological Evaluation of 3-Amino-5-(5-Oxo-5H-Benzo[a]Phenothiazin-6-Ylamino) Benzoic Acid Derivatives via Molecular Docking, Cytotoxicity, and Antioxidant Studies

  2019cites this paper
• In vitro and computational studies showed that perezone inhibits PARP-1 and induces changes in the redox state of K562 cells.

  2019cites this paper
• Olefination of Alkyl Halides with Aldehydes by Merging Visible-Light Photoredox Catalysis and Organophosphorus Chemistry

  2018cites this paper
• Synthetic Approaches to New Drugs Approved During 2016.

  2018cites this paper
• Investigation of chemical reactivity of 2-alkoxy-1,4-naphthoquinones and their anticancer activity.

  2018cites this paper
• The Antifungal Activity of Naphthoquinones: An Integrative Review.

  2018cites this paper
• Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity

  2018cites this paper
• Synthetic Approaches to the New Drugs Approved During 2015.

  2017cites this paper
• Three tetracyclic dibenzoazepine derivatives exhibiting different molecular conformations, different patterns of intermolecular hydrogen bonding and different modes of supramolecular aggregation.

  2017cites this paper
• Single step mechanism for nucleophilic substitution of 2,3-dichloro naphthoquinone using nitrogen, oxygen and sulfur nucleophiles: A DFT approach

  2017cites this paper
• Organocatalytic construction of spirooxindole naphthoquinones through Michael/hemiketalization using L-proline derived bifunctional thiourea

  2016cites this paper
• Palladium-catalyzed enantioselective Heck alkenylation of trisubstituted allylic alkenols: a redox-relay strategy to construct vicinal stereocenters

  2016cites this paper
• Synthetic approaches to the 2014 new drugs.

  2016cites this paper
• Synthetic approaches to the 2010-2014 new agrochemicals.

  2016cites this paper
• New page to access pyridine derivatives: synthesis from N-propargylamines

  2016cites this paper
• Synthetic methodologies leading to porphyrin-quinone conjugates

  2016cites this paper
• Synthesis of novel trans-stilbene derivatives containing a 4H-pyran-4-one unit and spectroscopic studies of two of their malononitrile derivatives

  2015cites this paper
• Palladium-catalyzed enantioselective Heck alkenylation of acyclic alkenols using a redox-relay strategy.

  2015cites this paper
• Understanding cancer and the anticancer activities of naphthoquinones – a review

  2015cites this paper
• Synthetic approaches to the 2013 new drugs.

  2015cites this paper
• Synthesis, molecular docking and antibacterial evaluation of 2-(4-(4-aminophenylsulfonyl)phenylamino)-3-(thiophen-2-ylthio)naphthalene-1,4-dione derivatives

  2015cites this paper
• Biflorin: an o-naphthoquinone of clinical significance.

  2014cites this paper
• Biflorin: an o-naphthoquinone of clinical significance.

  2014cites this paper
• Synthesis of multi-functional alkenes via Wittig reaction with a new-type of phosphorus ylides

  2014cites this paper
• Synthesis, characterization and molecular structures of homologated analogs of 2-bromo-3-(n-alkylamino)-1,4-napthoquinone

  2014cites this paper
• Synthetic approaches to the 2012 new drugs.

  2014cites this paper
• Biological Properties of 1H-1,2,3- and 2H-1,2,3-Triazoles

  2014cites this paper
• Part I: the development of the catalytic Wittig reaction.

  2013cites this paper
• Synthetic 1,4-Pyran Naphthoquinones Are Potent Inhibitors of Dengue Virus Replication

  2013cites this paper
• Synthesis and cytotoxic activity of metallic complexes of lawsone.

  2013cites this paper
• Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones

  2013cites this paper
• Synthetic approaches to the 2011 new drugs.

  2013cites this paper
• Ruthenium Compounds as Antitumor Agents: New Developments

  2013cites this paper
• Molecular structures and antiproliferative activity of side-chain saturated and homologated analogs of 2-chloro-3-(n-alkylamino)-1,4-napthoquinone

  2013cites this paper
• Industrielle Anwendungen der Diels‐Alder‐Reaktion

  2013cites this paper
• Industrial applications of the Diels-Alder reaction.

  2013cites this paper
• Synthesis, Molecular docking and Biological evaluation of 4-Cycloalkylidineamino 1, 2-Naphthoquinone Semicarbazones as Anticancer agents

  2012cites this paper
• Synthetic approaches to the 2010 new drugs.

  2012cites this paper
• Synthesis of Ethyl Nalidixate: A Medicinal Chemistry Experiment

  2012cites this paper
• Efficient Synthesis of 3‐Phenylnaphtho[2,3‐b]furan‐4,9‐diones in Water and Their Fluorimetric Study in Solutions

  2012cites this paper
• Synthesis, Characterization and Antiproliferative Activity of 1,2-Naphthoquinone and Its Derivatives

  2012cites this paper
• Zinc chloride-catalyzed one-pot, three-component synthesis of 5,8-dihydro-5,8-dioxo-4H-chromene derivatives

  2012cites this paper
• Green Synthesis of 3‐Hydroxynaphthalene‐1,4‐dione Derivatives via Microwave‐Assisted Three‐Component Reactions in Neat Water

  2012cites this paper
• Synthesis, characterization, in vitro anticancer activity, and docking of Schiff bases of 4-amino-1,2-naphthoquinone

  2012cites this paper
• Synthetic approaches to the 2009 new drugs.

  2011cites this paper
• Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.

  2011cites this paper
• Electronic and cytotoxic properties of 2-amino-naphtho[2,3-b]furan-4,9-diones.

  2011cites this paper
• Enantioselective organocatalytic Michael-hemiketalization catalyzed by a trans-bifunctional indane thiourea catalyst.

  2011cites this paper
• Evaluation of the cytotoxic and antimutagenic effects of biflorin, an antitumor 1,4 o-naphthoquinone isolated from Capraria biflora L

  2010cites this paper
• Strategies for the synthesis of bioactive pyran naphthoquinones.

  2010cites this paper
• 2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents.

  2009cites this paper
• Syntheses of chromenes and chromanes via o‐quinone methide intermediates

  2009cites this paper
• Synthetic approaches to the 2008 new drugs.

  2009cites this paper
• New potential inhibitors of DNA topoisomerase. Part II: Design and synthesis of alpha-lapachone derivatives under microwave irradiation.

  2009cites this paper
• Design and synthesis of a novel series of pyranonaphthoquinones as topoisomerase II catalytic inhibitors.

  2008cites this paper
• Synthetic approaches to the 2007 new drugs.

  2008cites this paper
• Synthesis and potent antitumor activity of new arylamino derivatives of nor-β-lapachone and nor-α-lapachone

  2007cites this paper
• Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.

  2007cites this paper
• From Racemates to Single Enantiomers - Chiral Synthetic Drugs over the last 20 Years.

  2007cites this paper
• Synthetic approaches to the 2005 new drugs.

  2007cites this paper
• Synthesis and potent antitumor activity of new arylamino derivatives of nor-beta-lapachone and nor-alpha-lapachone.

  2007cites this paper
• Synthetic approaches to the 2006 new drugs.

  2007cites this paper
• Synthetic approaches to the 2004 new drugs.

  2005cites this paper
• Synthetic Approaches to New Drugs (2003)

  2005cites this paper
• Synthetic approaches to the 2002 new drugs.

  2004cites this paper